~16 spots leftby Apr 2026

Lactated Ringer's Versus Normal Saline for Acute Pancreatitis

Recruiting in Palo Alto (17 mi)
JB
Overseen byJames Buxbaum, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Southern California
No Placebo Group

Trial Summary

What is the purpose of this trial?

Acute pancreatitis is a common problem in the United States necessitating 275,000 hospital admissions per year, with resultant healthcare costs of approximately 2.5 billion USD annually. As numerous trials have failed to show a benefit to specific pharmacologic therapies in acute pancreatitis, the mainstay of treatment has been both supportive care and early, aggressive fluid resuscitation. Small randomized studies have shown conflicting results with regards to the influence of resuscitation fluid on outcomes in acute pancreatitis, necessitating a large randomized trial to clarify if fluid choice matters or not in the treatment of acute pancreatitis. The objective of this study is to assess the comparative efficacy of normal saline versus lactated ringer's solution in the management of acute pancreatitis. Patients presenting to the Los Angeles County Hospital with acute pancreatitis will be randomized to fluid resuscitation with NS or LR with volumes of fluid administered according to a pre-determined algorithm that will be the same for both treatment arms. The primary outcome of the study will be the change in SIRS prevalence from enrollment to 24 hours. Secondary outcomes will include the change in SIRS prevalence from enrollment to 48 hours and 72 hours, development of moderately severe or severe pancreatitis, change in PASS score, ICU admission, length of hospitalization, persistent pain or disability after discharge, and time of advancement to oral diet and discharge.

Research Team

JB

James Buxbaum, MD

Principal Investigator

University of Southern California

Eligibility Criteria

Inclusion Criteria

Presentation with acute pancreatitis as defined by two of three criterion; amylase or lipase > 3x the upper limit of normal, classical abdominal pain, or imaging suggestive of pancreatitis. Such radiographic findings include swelling, edema, or heterogeneity of the gland or peripancreatic fluid or stranding.

Treatment Details

Interventions

  • Fluid administration (Other)
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Normal SalineExperimental Treatment1 Intervention
Patients will receive fluid administration of Normal Saline solution at a pre-determined volume algorithm that is the same for both arms
Group II: Lactated RingerActive Control1 Intervention
Patients will receive fluid administration of Lactated Ringer's solution at a pre-determined volume algorithm that is the same for both arms

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials
956
Recruited
1,609,000+
Dr. Samir A. profile image

Dr. Samir A.

University of Southern California

Chief Executive Officer since 2024

PhD in Molecular Biology from the University of Southern California

Dr. Chung profile image

Dr. Chung

University of Southern California

Chief Medical Officer since 2016

MD from UC San Diego